Regulatory consulting in Asia

Representing more than a third of the world’s population, the Asia-Pacific is an attractive option for cost-effective clinical research regardless of whether the target market for the product is within or outside the region. However, if the clinical research is not conducted efficiently, or to an appropriate level of quality, the anticipated savings can in fact lead to costly mistakes.

May ling, Stuart Mudge
IIR's Partnership Debuts in the Asia Pacific

2010 - Applied Clinical trials

Stuart Mudge, Senior Consultant Product Development

Stuart's focus was providing regulatory and project management services to a range of clients, typically emerging life science companies seeking to develop their products in the European and USA markets. At all times the goal was to deliver and implement development plans that were compatible with both Europe and the USA.


Download the full Publication now